Analysis of the causal effect (outcome) of selecting dexamethasone or methylprednisolone in the treatment of all COVID-19 patients (N = 1071)

Dexamethasone

N (%)

Methylprednisolone

N (%)

Difference

(%)

95% C.I.

P¹

Outcomes²

453 (42.3)

618 (57.7)

-----

Recovered

159

238

3.4

−9.4, 2.6

0.281

Residual symptoms³

16 (3.53)

27 (4.36)

0.8

−3.4, 1.7

0.595

Needs home O₂

233 (51.9)

254 (41.1)

10.3

4.12, 16

<0.001

Death

45 (9.9)

99 (16.0)

6.0

−10.3, −1.9

0.005